Viroblock SA Reports Positive Results of Preclinical Studies in Antiviral Nasal Spray
GENEVA, Switzerland, March 31 /PRNewswire/ -- Viroblock SA has announced today that the first generation of VCCD Tech antiviral nasal spray formulation is active against human influenza. Viroblock's…